141 related articles for article (PubMed ID: 28574091)
21. The Integrity of the YxxL Motif of Ebola Virus VP24 Is Important for the Transport of Nucleocapsid-Like Structures and for the Regulation of Viral RNA Synthesis.
Takamatsu Y; Kolesnikova L; Schauflinger M; Noda T; Becker S
J Virol; 2020 Apr; 94(9):. PubMed ID: 32102881
[TBL] [Abstract][Full Text] [Related]
22. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
23. Importin-α7 Is Involved in the Formation of Ebola Virus Inclusion Bodies but Is Not Essential for Pathogenicity in Mice.
Gabriel G; Feldmann F; Reimer R; Thiele S; Fischer M; Hartmann E; Bader M; Ebihara H; Hoenen T; Feldmann H
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S316-21. PubMed ID: 26185094
[TBL] [Abstract][Full Text] [Related]
24. How a virus blocks a cellular emergency access lane to the nucleus, STAT!
Daugherty MD; Malik HS
Cell Host Microbe; 2014 Aug; 16(2):150-152. PubMed ID: 25121743
[TBL] [Abstract][Full Text] [Related]
25. Designed Macrocyclic Peptides as Nanomolar Amyloid Inhibitors Based on Minimal Recognition Elements.
Spanopoulou A; Heidrich L; Chen HR; Frost C; Hrle D; Malideli E; Hille K; Grammatikopoulos A; Bernhagen J; Zacharias M; Rammes G; Kapurniotu A
Angew Chem Int Ed Engl; 2018 Oct; 57(44):14503-14508. PubMed ID: 29908130
[TBL] [Abstract][Full Text] [Related]
26. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
[TBL] [Abstract][Full Text] [Related]
27. Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host-cell protein function.
García-Dorival I; Wu W; Dowall S; Armstrong S; Touzelet O; Wastling J; Barr JN; Matthews D; Carroll M; Hewson R; Hiscox JA
J Proteome Res; 2014 Nov; 13(11):5120-35. PubMed ID: 25158218
[TBL] [Abstract][Full Text] [Related]
28. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
29. Macrocyclic α helical peptide therapeutic modality: A perspective of learnings and challenges.
Sawyer TK; Partridge AW; Kaan HYK; Juang YC; Lim S; Johannes C; Yuen TY; Verma C; Kannan S; Aronica P; Tan YS; Sherborne B; Ha S; Hochman J; Chen S; Surdi L; Peier A; Sauvagnat B; Dandliker PJ; Brown CJ; Ng S; Ferrer F; Lane DP
Bioorg Med Chem; 2018 Jun; 26(10):2807-2815. PubMed ID: 29598901
[TBL] [Abstract][Full Text] [Related]
30. Perfluoroarene-based peptide macrocycles that inhibit the Nrf2/Keap1 interaction.
Steel RJ; O'Connell MA; Searcey M
Bioorg Med Chem Lett; 2018 Sep; 28(16):2728-2731. PubMed ID: 29534931
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease.
Damalanka VC; Kim Y; Galasiti Kankanamalage AC; Lushington GH; Mehzabeen N; Battaile KP; Lovell S; Chang KO; Groutas WC
Eur J Med Chem; 2017 Feb; 127():41-61. PubMed ID: 28038326
[TBL] [Abstract][Full Text] [Related]
32. Fold prediction of VP24 protein of Ebola and Marburg viruses using de novo fragment assembly.
Lee MS; Lebeda FJ; Olson MA
J Struct Biol; 2009 Aug; 167(2):136-44. PubMed ID: 19447180
[TBL] [Abstract][Full Text] [Related]
33. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
34. De Novo Macrocyclic Peptide Inhibitors of Hepatitis B Virus Cellular Entry.
Passioura T; Watashi K; Fukano K; Shimura S; Saso W; Morishita R; Ogasawara Y; Tanaka Y; Mizokami M; Sureau C; Suga H; Wakita T
Cell Chem Biol; 2018 Jul; 25(7):906-915.e5. PubMed ID: 29779957
[TBL] [Abstract][Full Text] [Related]
35. [Immunobiological properties of vp24 protein of Ebola virus expressed by recombinant vaccinia virus].
Chepurnov AA; Ternovoĭ VA; Dadaeva AA; Dmitriev IP; Sizikova LP; Volchkov VE; Kudoiarova NM; Rudzevich TN; Netesov SV
Vopr Virusol; 1997; 42(3):115-20. PubMed ID: 9297340
[TBL] [Abstract][Full Text] [Related]
36. Structural and mechanistic insights into nuclear transport and delivery of the critical pluripotency factor Oct4 to DNA.
Okuyama T; Yamagishi R; Shimada J; Ikeda M; Maruoka Y; Kaneko H
J Biomol Struct Dyn; 2018 Feb; 36(3):767-778. PubMed ID: 28166455
[TBL] [Abstract][Full Text] [Related]
37. Rapid detection and quantification of Ebola Zaire virus by one-step real-time quantitative reverse transcription-polymerase chain reaction.
Ro YT; Ticer A; Carrion R; Patterson JL
Microbiol Immunol; 2017 Apr; 61(3-4):130-137. PubMed ID: 28332721
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Novel Dual Luciferase Reporter Gene Assay to Quantify Ebola Virus VP24 Inhibition of IFN Signaling.
Fanunza E; Frau A; Sgarbanti M; Orsatti R; Corona A; Tramontano E
Viruses; 2018 Feb; 10(2):. PubMed ID: 29495311
[TBL] [Abstract][Full Text] [Related]
39. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection.
Cilloniz C; Ebihara H; Ni C; Neumann G; Korth MJ; Kelly SM; Kawaoka Y; Feldmann H; Katze MG
J Virol; 2011 Sep; 85(17):9060-8. PubMed ID: 21734050
[TBL] [Abstract][Full Text] [Related]
40. Lead discovery and optimization strategies for peptide macrocycles.
Bhat A; Roberts LR; Dwyer JJ
Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
